Cargando…

Novel cell adhesion/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T cell lymphoma

BACKGROUND: Treatment for Cutaneous T Cell Lymphoma (CTCL) is generally not curative. Therefore, selecting therapy that is effective and tolerable is critical to clinical decision-making. Histone deacetylase inhibitors (HDACi), epigenetic modifier drugs, are commonly used but effective in only ~30%...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andrews, Jared M., Schmidt, Jennifer A., Carson, Kenneth R., Musiek, Amy C., Mehta-Shah, Neha, Payton, Jacqueline E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711861/ https://www.ncbi.nlm.nih.gov/pubmed/31358475 http://dx.doi.org/10.1016/j.ebiom.2019.07.053

Ejemplares similares

Selective inhibition of HDAC6 sensitizes cutaneous T-cell lymphoma to PI3K inhibitors
por: Bobrowicz, Malgorzata, et al.
Publicado: (2020)

United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic
por: Zic, John A., et al.
Publicado: (2020)

BET inhibition in advanced cutaneous T cell lymphoma is synergistically potentiated by BCL2 inhibition or HDAC inhibition
por: Kim, Sa Rang, et al.
Publicado: (2018)

DOT1L inhibition does not modify the sensitivity of cutaneous T cell lymphoma to pan-HDAC inhibitors in vitro
por: Kwesi-Maliepaard, Eliza Mari, et al.
Publicado: (2022)

The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma
por: Kim, Ellen J., et al.
Publicado: (2021)

Denileukin diftitox for the treatment of cutaneous T-cell lymphoma
por: Kaminetzky, David, et al.
Publicado: (2008)

Cutaneous T-cell lymphoma
por: Arora, Shalabh, et al.
Publicado: (2020)

Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma
por: Huang, Renhong, et al.
Publicado: (2018)

Histone Deacetylases (HDACs) Guided Novel Therapies for T-cell lymphomas
por: Zhang, Qing, et al.
Publicado: (2019)

HDAC inhibitors overcome immunotherapy resistance in B-cell lymphoma
por: Wang, Xiaoguang, et al.
Publicado: (2020)

Rapid and sustained response to immune checkpoint inhibition in cutaneous squamous cell carcinoma after allogenic hematopoietic cell transplant for sézary syndrome
por: Khaddour, Karam, et al.
Publicado: (2019)

Cutaneous T-Cell Lymphoma in Asians
por: Jang, Min Soo, et al.
Publicado: (2012)

An overview of cutaneous T cell lymphomas
por: Bagherani, Nooshin, et al.
Publicado: (2016)

Immunomodulation in Cutaneous T Cell Lymphoma
por: Ferranti, Martina, et al.
Publicado: (2019)

Editorial: Cutaneous T-Cell Lymphomas
por: Chung, Catherine G., et al.
Publicado: (2021)

Epigenetics of Cutaneous T-Cell Lymphomas
por: Hara, Natsumi, et al.
Publicado: (2022)

Signet-ring cutaneous metastasis presenting with massive anasarca
por: Raval, Neel, et al.
Publicado: (2021)

Dupilumab Treatment in Two Patients with Cutaneous T-cell Lymphomas
por: LAZARIDOU, Ingrid, et al.
Publicado: (2020)

Refractory mogamulizumab-associated rash responding to an oral Janus kinase inhibitor
por: Lama, Carine M., et al.
Publicado: (2023)

Hedgehog inhibitors selectively target cell migration and adhesion of mantle cell lymphoma in bone marrow microenvironment
por: Zhang, Han, et al.
Publicado: (2016)

Recent Update of HDAC Inhibitors in Lymphoma
por: Chen, I-Chung, et al.
Publicado: (2020)

Peroxisomes protect lymphoma cells from HDAC inhibitor-mediated apoptosis
por: Dahabieh, Michael S, et al.
Publicado: (2017)

Interstitial cell migration: integrin-dependent and alternative adhesion mechanisms
por: Schmidt, Samuel, et al.
Publicado: (2009)

Sustained remission of recalcitrant cutaneous lymphoid hyperplasia after thalidomide treatment
por: Erickson, Stephen P., et al.
Publicado: (2018)

Expression of HAT1 and HDAC1, 2, 3 in Diffuse Large B-Cell Lymphomas, Peripheral T-Cell Lymphomas, and NK/T-Cell Lymphomas
por: Min, Soo Kee, et al.
Publicado: (2012)

An unusual presentation of metastatic disease: Cutaneous metastases from pulmonary adenocarcinoma manifesting as widespread plaques
por: Brown, Danielle Nicole, et al.
Publicado: (2015)

Allogeneic hematopoietic stem cell transplantation for primary cutaneous T cell lymphomas
por: Paralkar, Vikram R., et al.
Publicado: (2011)

Pin1 coordinates HDAC6 upregulation with cell migration in lung cancer cells
por: Chuang, Hsiang-Hao, et al.
Publicado: (2020)

Romidepsin in the treatment of cutaneous T-cell lymphoma
por: Jain, Salvia, et al.
Publicado: (2011)

CUTANEOUS INVOLVEMENT IN ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA
por: Papadavid, Evangelia, et al.
Publicado: (2010)

Genomic landscape of cutaneous T cell lymphoma
por: Choi, Jaehyuk, et al.
Publicado: (2015)

Cutaneous T-Cell Lymphoma with Nasal Necrosis
por: Shaum, Katherine, et al.
Publicado: (2015)

Update on Biology of Cutaneous T-Cell Lymphoma
por: Phyo, Zaw H., et al.
Publicado: (2020)

Nivolumab-associated cutaneous T-cell lymphoma
por: Marks, Jennifer A., et al.
Publicado: (2021)

Editorial: Cutaneous B-Cell Lymphomas
por: Alaibac, Mauro, et al.
Publicado: (2020)

Alitretinoin in the treatment of cutaneous T‐cell lymphoma
por: Kaemmerer, Till, et al.
Publicado: (2021)

What Is New in Cutaneous T Cell Lymphoma?
por: Morgenroth, Sarah, et al.
Publicado: (2023)

HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma
por: Ramakrishnan, Swathi, et al.
Publicado: (2016)

Primary Cutaneous Peripheral T-Cell Lymphoma Not Otherwise Specified: A Rapidly Progressive Variant of Cutaneous T-Cell Lymphoma
por: Aderhold, Kimberly, et al.
Publicado: (2015)

Methotrexate-induced Primary Cutaneous Diffuse Large B-cell Lymphoma in Patients with Erythrodermic Cutaneous T-cell Lymphoma
por: DELALEU, Jérémie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j9pf8fj0lgo8cnfa1jm2bd10t8